| Pharmaceutical active ingredients: |
| Ergoloid Mesylates |
| Available forms, composition and doses of Ergoplus: |
| N / A |
| Ergoplus medical category: |
| Human:Sympatholytic (adrenergic blocking) agents |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C04AE01 - Ergoloid Mesylates |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Hormosan Pharma |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ergont | Dihydroergotamine Mesylate | Desitin Arzneimittel; Cimex Pharmazeutika; Sigmapharm Arzneimittel |
| Ergont Depot | Dihydroergotamine Mesylate | Desitin Arzneimittel |
| Ergont Retard | Dihydroergotamine Mesylate | Desitin Arzneimittel |
| Ergophen | Belladonna dry extract; Ergotamine Tartrate; Phenobarbital | Inga Laboratories |
| Ergoplex | Ergoloid Mesylates | F. Joh. Kwizda |
| Ergoram | Amino Acids | Bonomelli Divisione Farmacia |
| Ergoriv | Methylergonovine | East African India Overseas |
| Ergorone | Vitamin D2 | Unidentified Pharmaceutical Company |
| Ergosanol a la Cafeine Suppositories | Caffeine; Caffeine Citrate; Ergotamine Tartrate; Ethenzamide | Globopharm |
| Ergosanol a la Cafeine Tablets | Caffeine; Ergotamine Tartrate; Ethenzamide | Globopharm |